Abeona Therapeutics Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Abeona Therapeutics Inc. Common Stock (ABEO) has a 3-month relative strength percentile of 80 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.0%, relative volume 2.84×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 80, Market Stance is mixed at 47, A/D rating D
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
ABEO is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $7M notional. Top 3 carry $15M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $7M |
| IWMiShares Russell 2000 ETF | 0.01% | $5M |
| VXFVanguard Extended Market ETF | 0.00% | $3M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $2M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $521K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABEO Jan avg: -10.22% median: -10.80% win: 0% σ: 9.60% n: 4 2022-04-12 → 2026-05-29 | ABEO Feb avg: 13.89% median: -2.41% win: 50% σ: 37.31% n: 4 2022-04-12 → 2026-05-29 | ABEO Mar avg: 1.64% median: -2.04% win: 50% σ: 16.24% n: 4 2022-04-12 → 2026-05-29 | ABEO Apr avg: -0.36% median: 8.87% win: 60% σ: 33.84% n: 5 2022-04-12 → 2026-05-29 | ABEO May avg: -2.21% median: 0.65% win: 60% σ: 10.12% n: 5 2022-04-12 → 2026-05-29 | ABEO Jun avg: 10.46% median: 10.20% win: 50% σ: 19.45% n: 4 2022-04-12 → 2026-05-29 (current) | ABEO Jul avg: -2.82% median: -1.49% win: 50% σ: 19.63% n: 4 2022-04-12 → 2026-05-29 | ABEO Aug avg: 11.25% median: 11.77% win: 75% σ: 15.81% n: 4 2022-04-12 → 2026-05-29 | ABEO Sep avg: -8.32% median: -10.72% win: 25% σ: 14.75% n: 4 2022-04-12 → 2026-05-29 | ABEO Oct avg: 8.56% median: -3.74% win: 50% σ: 28.71% n: 4 2022-04-12 → 2026-05-29 | ABEO Nov avg: 3.17% median: 2.55% win: 50% σ: 18.02% n: 4 2022-04-12 → 2026-05-29 | ABEO Dec avg: -5.65% median: -4.44% win: 50% σ: 11.53% n: 4 2022-04-12 → 2026-05-29 |